Literature DB >> 16213485

Focus on molecules: lumican.

Winston W-Y Kao1, James L Funderburgh, Ying Xia, Chia-Yang Liu, Gary W Conrad.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16213485      PMCID： PMC2876311          DOI： 10.1016/j.exer.2005.08.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN： 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  4 in total

1.  Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan.

Authors:  J L Funderburgh; R R Mitschler; M L Funderburgh; M R Roth; S K Chapes; G W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-05       Impact factor: 4.799

2.  Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican.

Authors:  Eric C Carlson; Chia-Yang Liu; Tai-ichiro Chikama; Yasuhito Hayashi; Candace W-C Kao; David E Birk; James L Funderburgh; James V Jester; Winston W-Y Kao
Journal:  J Biol Chem       Date:  2005-04-22       Impact factor: 5.157

3.  Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma.

Authors:  S Chakravarti; W M Petroll; J R Hassell; J V Jester; J H Lass; J Paul; D E Birk
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

Review 4.  Roles of lumican and keratocan on corneal transparency.

Authors:  Winston W-Y Kao; Chia-Yang Liu
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916
  4 in total
  33 in total

Review 1.  Cell Therapy of Corneal Diseases.

Authors:  Winston W-Y Kao; Vivien J Coulson-Thomas
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

2.  Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking.

Authors:  Yuntao Zhang; Abigail H Conrad; Gary W Conrad
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

3.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

Review 4.  The molecular basis of corneal transparency.

Authors:  John R Hassell; David E Birk
Journal:  Exp Eye Res       Date:  2010-07-03       Impact factor: 3.467

5.  Corneal stromal bioequivalents secreted on patterned silk substrates.

Authors:  Jian Wu; Jelena Rnjak-Kovacina; Yiqin Du; Martha L Funderburgh; David L Kaplan; James L Funderburgh
Journal:  Biomaterials       Date:  2014-02-03       Impact factor: 12.479

6.  Enhanced cell accumulation and collagen processing by keratocytes cultured under agarose and in media containing IGF-I, TGF-β or PDGF.

Authors:  LaTia Etheredge; Bradley P Kane; Nikola Valkov; Sheila Adams; David E Birk; John R Hassell
Journal:  Matrix Biol       Date:  2010-05-24       Impact factor: 11.583

7.  Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.

Authors:  Hongshan Liu; Jianhua Zhang; Chia-Yang Liu; I-Jong Wang; Martin Sieber; John Chang; James V Jester; Winston W Y Kao
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Lumican regulates ventilation-induced epithelial-mesenchymal transition through extracelluar signal-regulated kinase pathway.

Authors:  Li-Fu Li; Pao-Hsien Chu; Cheng-Yiu Hung; Winston W-Y Kao; Meng-Chih Lin; Yung-Yang Liu; Cheng-Ta Yang
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Human primary corneal fibroblasts synthesize and deposit proteoglycans in long-term 3-D cultures.

Authors:  R Ren; A E K Hutcheon; X Q Guo; N Saeidi; S A Melotti; J W Ruberti; J D Zieske; V Trinkaus-Randall
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

10.  Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.

Authors:  Anuradha Krishnan; Xia Li; Winstonwhei-Yang Kao; Kimberly Viker; Kim Butters; Howard Masuoka; Bruce Knudsen; Gregory Gores; Michael Charlton
Journal:  Lab Invest       Date:  2012-09-24       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.